A Prospective, Monocentric Study Assessing Impact of Posaconazole Prophylaxis on Fungal Colonisation and Invasive Fungal Infections in Patients Receiving Posaconazole Prophylaxis for Graft Versus Host Disease (GVHD) after Hematopoietic Stem Cell Transplantation (HSCT) or Chemotherapy for Acute Myeloid Leukemia (AML)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 03 Jul 2017

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Posaconazole (Primary)
Indications Mycoses
Focus Pharmacokinetics; Therapeutic Use

Most Recent Events

03 Jul 2017 New trial record
05 Jun 2017 Results presented at the ASM Microbe 2017.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight

Ask the expert

Thank you

At a glance

Most Recent Events

You need to be a logged in or subscribed to view this content Request demo

Table of Contents